Mörsdorf S, Pistorius G, Orthleb R, Pindur G, Schenk J
Abteilung für klinische Hämostaseologie und Transfusionsmedizin, Universitätskliniken des Saarlandes.
Dtsch Med Wochenschr. 1999 Oct 29;124(43):1271-4. doi: 10.1055/s-2007-1024531.
An 80-year-old woman had been hospitalized in a psychiatric clinic where, on the 22nd day, she sustained a fracture of the neck of the left femur, which was treated by internal screw fixation. The postoperative course was at first without complication. But 9 days postoperatively her platelet count had fallen to 59,000/microliter. As heparin induced type II thrombocytopenia (HIT II) was suspected, the thrombosis prophylaxis with low-molecular heparin was replaced by sodium danaparoid (twice 750 units subcutaneously). Despite this, ischaemia of the right lower leg developed and required amputation. On the following day the left lower leg and foot also became ischemic, where upon she was admitted to the author's hospital (37 days after her admission to the psychiatric clinic).
The patient was in a reduced general condition (body-mass index 19.5 kg/m2). She was disoriented as to place and time. Her blood pressure was 140/80 mmHg, her pulse irregular with a ventricular rate of 100/min. The skin below the middle of the left lower leg was cold and livid and the pedal pulses were not palpable.
Haemoglobin content was 9.7 g/dl, the white cell count 9,200/microliter, and platelet count 54,000/microliter. Electrolytes and creatinine were within normal limits.
Thrombendarterectomy was performed once via the left groin under danaparoid anticoagulation. There was no re-occlusion and the patient was able to walk again.--It was ascertained subsequently, she had already been given ordinary heparin in the psychiatric clinic for 20 days. Her platelet count of around 70,000/microliter returned to normal even though heparin administration was continued.
A reduction in platelet count by more than half during heparin treatment suggests heparin-induced thrombocytopenia, in which case heparin should be discontinued at once. In high-risk patients adequate treatment should be initiated with other anticoagulants even before the occurrence of thromboembolism.
一名80岁女性曾在一家精神病诊所住院,在住院第22天时,她左侧股骨颈骨折,接受了内固定螺钉治疗。术后初期无并发症。但术后9天,她的血小板计数降至59,000/微升。由于怀疑是肝素诱导的II型血小板减少症(HIT II),低分子肝素的血栓预防措施被达那肝素钠替代(皮下注射两次,每次750单位)。尽管如此,右下肢仍发生缺血并需要截肢。次日,左下肢和足部也出现缺血,随后她被收治到作者所在医院(入住精神病诊所37天后)。
患者一般状况较差(体重指数19.5kg/m²)。她对地点和时间定向障碍。血压为140/80mmHg,脉搏不规则,心室率为100次/分钟。左小腿中部以下皮肤冰冷、青紫,足部脉搏触不到。
血红蛋白含量为9.7g/dl,白细胞计数为9,200/微升,血小板计数为54,000/微升。电解质和肌酐在正常范围内。
在达那肝素抗凝治疗下,经左腹股沟进行了一次血栓内膜切除术。没有再次闭塞,患者能够再次行走。——随后确定,她在精神病诊所已接受普通肝素治疗20天。尽管继续使用肝素,她的血小板计数约70,000/微升恢复了正常。
肝素治疗期间血小板计数减少一半以上提示肝素诱导的血小板减少症,在这种情况下应立即停用肝素。在高危患者中,即使在血栓栓塞发生之前,也应开始使用其他抗凝剂进行充分治疗。